Latest Biotech News

Researchers at Rice University developed a novel fluorescent probe named AnapTh, enabling real-time visualization of localized environmental changes within specific protein subdomains in living...

A team led by Altuna Akalin at the Max Delbrück Center introduced Flexynesis, a deep learning toolkit designed for flexible integration of multi-omics datasets—including DNA, RNA, and protein...

MGI Tech unveiled the DNBSEQ-T7+ sequencer, an advanced instrument aimed at meeting rising throughput demands in population genomics, multiomics, and precision medicine. This scalable platform...

A collaborative research team from POSTECH and Inha University developed a novel artificial protein that synergizes mechanical elasticity with cell signaling capabilities, markedly enhancing...

Despite the Phase 3 failure of efzofitimod to significantly reduce steroid dependence in pulmonary sarcoidosis, aTyr Pharma intends to engage regulatory authorities to explore possible pathways...

Novartis has expanded its collaboration with Monte Rosa Therapeutics by securing exclusive rights to a new molecular glue degrader drug candidate and options for two additional programs, paying...

aTyr Pharma’s lead drug candidate efzofitimod missed its primary endpoint in a Phase 3 trial for pulmonary sarcoidosis, an inflammatory lung disease. The therapy failed to significantly reduce...

Novo Nordisk revealed plans to reduce its workforce by approximately 11.5%, cutting around 9,000 jobs globally as part of a major restructuring initiative. The move aims to streamline management...

The FDA has granted full approval to Precigen’s Papzimeos (zopapogene imadenovec-drba), the first medical therapy for recurrent respiratory papillomatosis (RRP), a rare respiratory disorder caused...

Researchers led by Altuna Akalin at the Max Delbrück Center developed Flexynesis, a deep learning toolkit designed to integrate multi-omics data alongside clinical and imaging information to...

Bar-Ilan University and Sheba Medical Center have established a joint research institute with a $120 million investment, located in Israel’s Health Tech Valley in Ramat Gan. This collaboration...

Lila Sciences, a Flagship Pioneering-backed startup, secured $235 million in a Series A financing round to develop AI-based 'scientific superintelligence' platforms aimed at accelerating drug...

South Korea’s Ministry of Food and Drug Safety announced plans to significantly increase the application fees for biosimilar drug approvals starting in 2026, while simultaneously shortening review...

Biocartis secured FDA premarket approval for its Idylla CDx MSI Test, a rapid, automated assay to identify colorectal cancer patients with microsatellite instability-high (MSI-H) who may benefit...

aTyr Pharma's experimental drug efzofitimod failed its Phase 3 trial in pulmonary sarcoidosis, missing the primary goal of significantly reducing steroid use compared to placebo. Despite some...

Novartis has expanded its collaboration with Monte Rosa Therapeutics, signing a new agreement with $120 million upfront and potential payments up to $5.7 billion. The deal secures Novartis...

Biocartis received FDA premarket approval for its Idylla CDx MSI test designed to identify colorectal cancer patients with microsatellite instability-high tumors who may benefit from immunotherapy...

The FDA granted full approval to Precigen's Papzimeos, a non-replicating adenoviral vector immunotherapy targeting human papillomavirus (HPV) types 6 and 11 to treat recurrent respiratory...

Mount Sinai Fuster Heart Hospital inaugurated the Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab, integrating AI technologies with cardiac catheterization procedures....

AI startup Lila Sciences is closing a $235 million Series A funding round to develop scientific superintelligence that integrates artificial intelligence deeply into laboratory research. The...